CNS Pharmaceuticals, Inc. (CNSP) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time CNSP price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 55.2 Neutral
Market Cap $8.0M
Volume 2.9K
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $-4.9M
EPS $-7.30
P/E Ratio -0.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Charles Faith L. | Director | Buy | 7,100 | $4.79 | $34,002 | 2026 May 18 |
| Climaco John M | Chief Executive Officer | Buy | 166,666 | $0.30 | $50,000 | 2024 Feb 1 |
| Downs Christopher | Chief Financial Officer | Buy | 66,666 | $0.30 | $20,000 | 2024 Feb 1 |
| Gumulka Jerzy | Director | Buy | 33,333 | $0.30 | $10,000 | 2024 Feb 1 |
| Evans Carl Anthony | Director | Buy | 33,333 | $0.30 | $10,000 | 2024 Feb 1 |
| Downs Christopher | Chief Financial Officer | Buy | 27,000 | $1.27 | $34,290 | 2023 Aug 22 |
| Climaco John M | Chief Executive Officer | Buy | 2,750 | $1.80 | $4,950 | 2023 Aug 16 |
| Gumulka Jerzy | Director | Buy | 2,500 | $1.70 | $4,250 | 2023 Apr 19 |
| Downs Christopher | Chief Financial Officer | Buy | 3,100 | $3.20 | $9,920 | 2023 Apr 17 |
| Climaco John M | Chief Executive Officer | Buy | 15,000 | $0.69 | $10,350 | 2023 Apr 12 |
| Gumulka Jerzy | Director | Buy | 7,173 | $0.74 | $5,308 | 2023 Apr 10 |
| Priebe Waldemar | 10% Owner | Sell | 94,298 | $1.41 | $133,114 | 2023 Mar 28 |
| Downs Christopher | Chief Financial Officer | Buy | 5,000 | $0.94 | $4,700 | 2021 Dec 6 |
| Downs Christopher | Chief Financial Officer | Buy | 4,500 | $1.15 | $5,175 | 2021 Nov 19 |
| Downs Christopher | Chief Financial Officer | Buy | 142,000 | $2.04 | $289,680 | 2020 Aug 24 |
Take CNSP further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put CNSP in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when CNS Pharmaceuticals, Inc. next reports.
Set alerts on CNSP
Get notified when CNS Pharmaceuticals, Inc. hits your price targets or technical conditions are met.
Get Started Free